[PDF][PDF] The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment

H Rodriguez, JC Zenklusen, LM Staudt, JH Doroshow… - Cell, 2021 - cell.com
When it comes to precision oncology, proteogenomics may provide better prospects to the
clinical characterization of tumors, help make a more accurate diagnosis of cancer, and …

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

ETH Fontham, AMD Wolf, TR Church… - CA: a cancer journal …, 2020 - Wiley Online Library
Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

[HTML][HTML] Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices

E Meites - MMWR. Morbidity and mortality weekly report, 2019 - cdc.gov
Background HPV is a common sexually transmitted infection, with HPV acquisition generally
occurring soon after first sexual activity (1). Most HPV infections are transient and …

Epidemiology of HPV related malignancies

N Scott-Wittenborn, C Fakhry - Seminars in radiation oncology, 2021 - Elsevier
Human papillomavirus is the most common sexually transmitted infection in the world and
had been linked to both anogenital and oropharyngeal cancers. It causes nearly 100% of …

[HTML][HTML] Sexually transmitted infections treatment guidelines, 2021

KA Workowski - MMWR. Recommendations and Reports, 2021 - cdc.gov
These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

[HTML][HTML] Declines in prevalence of human papillomavirus vaccine-type infection among females after introduction of vaccine—United States, 2003–2018

HG Rosenblum - MMWR. Morbidity and Mortality Weekly Report, 2021 - cdc.gov
Nationally representative data through 2018 indicate that HPV vaccine-type prevalence
continues to decline among females aged 14–19 (88%) and 20–24 (81%) years compared …

[HTML][HTML] National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2018

TY Walker - MMWR. Morbidity and mortality weekly report, 2019 - cdc.gov
In 2018, adolescent vaccination coverage in the United States continued to improve for
meningococcal and HPV vaccines (primarily from increases among boys) and remains high …

[HTML][HTML] National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2017

TY Walker - MMWR. Morbidity and mortality weekly report, 2018 - cdc.gov
In 2017, coverage among adolescents aged 13–17 years increased for≥ 1 dose of HPV
vaccine and≥ 1 and≥ 2 doses of meningococcal vaccines and remained high for≥ 1 dose …

Estimated prevalence and incidence of disease-associated human papillomavirus types among 15-to 59-year-olds in the United States

RM Lewis, JF Laprise, JW Gargano… - Sexually transmitted …, 2021 - journals.lww.com
Methods Prevalence and incidence were estimated for infections with any HPV (any of 37
types detected using Linear Array) and disease-associated HPV, 2 types that cause …

Significant declines in juvenile-onset recurrent respiratory papillomatosis following human papillomavirus (HPV) vaccine introduction in the United States

E Meites, L Stone, R Amiling, V Singh… - Clinical Infectious …, 2021 - academic.oup.com
Background Juvenile-onset recurrent respiratory papillomatosis (JORRP) is a rare and
serious disease caused by human papillomavirus (HPV) presumably acquired during …